NCT07219953
ClinicalTrials.gov
- Trial ID
- T-ctgov-NCT07219953
- Registry
- ClinicalTrials.gov
- NCT number
- NCT07219953
- CTIS number
- 2025-522312-16-00
- Sponsor, as registered
- Eli Lilly and Company
- Phase
- PHASE3
- Indication
- Alcohol Use Disorder
- Status
- RECRUITING
- Start date
- 2025-10-16
- Primary completion
- 2028-04
- Registered countries
- Belgium, China, Germany, Japan, South Korea, Taiwan, United Kingdom, United States
- Sites
- 115
The sponsor's registered location list, which states intent rather than approval.
clinicaltrials.govctgov registryverified 2026-11-07
Notes on the record
Supersedes the row verified 2026-09-28 (kept), per DATA LAYER rule 4. Read live from the ClinicalTrials.gov v2 API 2026-11-07 (https://clinicaltrials.gov/api/v2/studies/NCT07219953); record last update posted 2026-11-04. site_count 116 to 115 location entries; status, dates and the eight countries unchanged. Flagged by the collector (inbox/2026-11-05.json); collector proposal replaced by this live read.
Company
Through brenipatide (LY3537031): Lilly
Cited in
Issues quoting NCT07219953 in their own text.